Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Can/Fite BioPharma Ltd/

Recent news which mentions Can/Fite BioPharma Ltd/

Multiple Shots On Goal: Can-Fite's Late-Stage Clinical Pipeline Hits Positive Results
Tickers CANF
Tags General Partner Content Market News
From Benzinga
This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers
Tickers AMGN BMY CANF
Tags Market News Partner Content BMY
From Benzinga
Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
Tickers ABBV AMGN CANF NVS
Tags General Partner Content Biotech
From Benzinga
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
Tickers AMGN CANF NVS
Tags Health Care AMGN Penny Stocks
From Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
Tickers ABBV AMGN BMY CANF
Tags CANF ABBV AMGN
From Benzinga
A New Oral Therapy for Psoriasis Could Be Coming Soon
Tickers ABBV AMGN CANF NVS
Tags Partner Content General Biotech
From Benzinga
PRIOR TO PHASE III PSORIASIS DATA RELEASE CAN FITE REPORTS THAT PICLIDENOSON DESTROYS PATHOLOGICAL SKIN CELLS IN VITRO
Tickers CANF
Tags Partner Content Market News General
From Benzinga
Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference
Tickers CANF CFBI
Tags Health Care Penny Stocks CFBI
From Benzinga
Dawson James - Can-Fite (CANF) Buy Rated - Expected Milestones
Tickers CANF
Tags Partner Content Benzinga Market News
From Benzinga
CAN-FITE ISSUES LETTER TO SHAREHOLDERS
Tickers CANF
Tags Press Releases Penny Stocks Benzinga
From Benzinga
FOLLOWING COMPLETE CLEARANCE OF CANCER LESIONS IN ADVANCED LIVER CANCER PATIENT, CAN-FITE IS FILING PATENT APPLICATIONS FOR THE TREATMENT OF VARIOUS ADVANCED SOLID TUMORS
Tickers CANF
Tags Partner Content Market News General
From Benzinga
Positive Data from Phase IIa Can-Fite NASH Study Published in Leading Peer Reviewed Scientific Journal
Tickers CANF CFBI
Tags General Partner Content Market News
From Benzinga
Hope on the Horizon for Liver Cancer Patients as This Company's Namodenoson Drug Starts Pivotal Phase III Global Trial
Tickers CANF
Tags General Market News Partner Content
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.